Management of Familial Melanoma and Nonmelanoma Skin Cancer Syndromes

被引:11
作者
Santillan, Alfredo A. [1 ]
Cherpelis, Basil S. [1 ,2 ]
Glass, L. Frank [1 ,2 ,3 ]
Sondak, Vernon K. [1 ,4 ,5 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Div Cutaneous Oncol, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Med, Dept Dermatol, Tampa, FL 33612 USA
[3] Univ S Florida, Coll Med, Dept Pathol & Cell Biol, Tampa, FL 33612 USA
[4] Univ S Florida, Coll Med, Dept Oncol Sci, Tampa, FL 33612 USA
[5] Univ S Florida, Coll Med, Dept Surg, Tampa, FL 33612 USA
关键词
Melanoma; Familial atypical multiple mole melanoma; Hereditary skin cancer syndromes; CUTANEOUS MALIGNANT-MELANOMA; VITAMIN-D-RECEPTOR; DYSPLASTIC NEVUS SYNDROME; AMERICAN JOINT COMMITTEE; CDK4 GERMLINE MUTATIONS; ATYPICAL-MOLE SYNDROME; MC1R GENE VARIANTS; PRONE FAMILIES; RISK-FACTORS; CDKN2A MUTATIONS;
D O I
10.1016/j.soc.2008.08.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The clinical manifestations of hereditary skin cancer syndromes depend upon theinterplay between environmental and genetic factors. Familial melanoma occurs in the setting of hereditary susceptibility, with a complex phenotype of early age of onset, multiple atypical moles, multiple primary melanomas, multiple melanomas in the family, and in some instances pancreatic cancer. Identification of individuals who may have a hereditary susceptibility for the development of melanoma is essential to provide an opportunity for primary prevention, and to target high-risk groups for early diagnosis and treatment. Consequently, the surgeon as one of the primary caregivers should be familiar with hereditary skin cancer syndromes and their pathogenesis, diagnosis, management, and surveillance recommendations. This article discusses a practical approach for some of the issues likely encountered by the surgeon in the management of familial melanoma and nonmelanomaskin cancer.
引用
收藏
页码:73 / +
页数:27
相关论文
共 139 条
  • [1] ANDERSON DE, 1991, ANTICANCER RES, V11, P433
  • [2] Bafounta ML, 2001, ARCH DERMATOL, V137, P1343
  • [3] Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system
    Balch, CM
    Soong, SJ
    Gershenwald, JE
    Thompson, JF
    Reintgen, DS
    Cascinelli, N
    Urist, M
    McMasters, KM
    Ross, MI
    Kirkwood, JM
    Atkins, MB
    Thompson, JA
    Coit, DG
    Byrd, D
    Desmond, R
    Zhang, YT
    Liu, PY
    Lyman, GH
    Morabito, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) : 3622 - 3634
  • [4] Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma
    Balch, CM
    Buzaid, AC
    Soong, SJ
    Atkins, MB
    Cascinelli, N
    Coit, DG
    Fleming, ID
    Gershenwald, JE
    Houghton, A
    Kirkwood, JM
    McMasters, KM
    Mihm, MF
    Morton, DL
    Reintgen, DS
    Ross, MI
    Sober, A
    Thompson, JA
    Thompson, JF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) : 3635 - 3648
  • [5] Incidence of new and changed Nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma
    Banky, JP
    Kelly, JW
    English, DR
    Yeatman, JM
    Dowling, JP
    [J]. ARCHIVES OF DERMATOLOGY, 2005, 141 (08) : 998 - 1006
  • [6] The melanocortin-1-receptor gene is the major freckle gene
    Bastiaens, M
    ter Huurne, J
    Gruis, N
    Bergman, W
    Westendorp, R
    Vermeer, BJ
    Bavinck, JNB
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (16) : 1701 - 1708
  • [7] Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair
    Bastiaens, MT
    ter Huurne, JAC
    Kielich, C
    Gruis, NA
    Westendorp, RGJ
    Vermeer, BJ
    Bavinck, NJB
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (04) : 884 - 894
  • [8] Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: A case-control study
    Bataille, V
    Bishop, JAN
    Sasieni, P
    Swerdlow, AJ
    Pinney, E
    Griffiths, K
    Cuzickz, J
    [J]. BRITISH JOURNAL OF CANCER, 1996, 73 (12) : 1605 - 1611
  • [9] Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample
    Begg, CB
    Orlow, I
    Hummer, AJ
    Armstrong, BK
    Kricker, A
    Marrett, LD
    Millikan, RC
    Gruber, SB
    Anton-Culver, H
    Zanetti, R
    Gallagher, RP
    Dwyer, T
    Rebbeck, TR
    Mitra, N
    Busam, K
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (20): : 1507 - 1515
  • [10] Human melanocyte senescence and melanoma susceptibility genes
    Bennett, DC
    [J]. ONCOGENE, 2003, 22 (20) : 3063 - 3069